Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

von Hippel-Lindau Disease × tanespimycin × 90 days × Clear all

Sponsor

Interventions

belzutifan 2 Everolimus 2 spartalizumab 1 palbociclib 1 lenvatinib 1 gallium Ga 68 dotatate 1 cabozantinib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡